Dr Abbas Green
Chief Medical Officer

• Advises Biotivia board on safety and efficacy

• Product development for men’s health formulations

• Combines medical and naturopathic qualifications

• Serves as Biotivia’s liaison with the medical community

Dr Abbas Green, M.D. MBBCh, MRCGP, FRCSI,  FEBU, FRCS, UROL

Chief Medical Officer, Biotivia.

Based at his specialist clinic in London’s Harley Street, Dr Green combines a career as a physician specialising in urology and andrology with lecturing appointments in the field of naturopathy.

Dr Green qualified as a physician at the University of Wales College of Medicine, Cardiff, UK. His post-graduate training was in general practice and urology. He is board certified for both those specialties. Dr Green also has a qualification in urology from the UK’s Royal College of Surgeons and is a fellow of the European Board of Urology and is trained in nutritional medicine and naturopathy.

At Biotivia, Dr Green is responsible for advising on medical and pharmaceutical matters and developing natural formulations in the areas of men’s health with a focus on endocrine related conditions and  prostate health. As a specialist in urology, Dr Green has world-class training and experience in prostate and erectile dysfunction health issues. He has received numerous research grants and awards in the field of men’s health.

In addition to his medical qualifications, Dr Green has a diploma in naturopathic medicine. He is a regular lecturer at naturopathic colleges and clinics, and also lectures at St Georges’ Hospital Medical School, London, for the faculty of community medicine.

Dr Green’s combination of family physician qualifications, urology, and nutritional medicine specializations, and his unique naturopathic insights make him a perfect fit for the position of Chief Medical Officer at Biotivia. One of Dr Green’s formulations for prostiatitis, which is being developed in conjunction with the research team at Biotivia, is being prepared for human trials at three medical facilities in Europe. Dr Green advises the Biotivia board on safety and efficacy regarding new formulations and serves as Biotivia’s liaison to the medical community.

Dr Green will also be involved in resveratrol and pterostilbene research projects. Biotivia’s products have been used in numerous clinical studies throughout the world, including:

• The University of Queensland Diamantina Institute, Princess Alexandra Hospital.
• Albert Einstein Medical College, USA. (Pre-diabetes).
• University of Northumbria, UK. (Brain blood flow and Cogntive function).
• University of Ferrara, Italy. (Beta Thalassemia).
• Stoney Brook Medical College, USA.
• Turin University Medical School.
• Ottawa Hospital.
• Toronto Hospital.

Researchers should also visit www.biotivia.com/researchers.html